Total Pharmacy |

At the American Associated Pharmacies Annual Conference, Douglas Hoey, RPh, MBA, discussed what needs to change in the program so that it does not hurt pharmacies and patients.

A conversation with Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS, at the American Associated Pharmacies 2025 Annual Conference.

Collaborative practice agreements enable pharmacists to leverage their expertise beyond traditional dispensing, but barriers continue to limit their implementation.

David Blair, CEO of LucyRx, discusses the common challenges his clients face and how his company’s innovative model can help them overcome financial hurdles.

A conversation with Scott Biggs and Greg Mitchell at the American Associated Pharmacies 2025 Annual Conference.

A conversation with Douglas Hoey, CEO of the National Community Pharmacists Association, at the American Associated Pharmacies 2025 Annual Conference.

Researchers explored various types of self-expression among pharmacists and how they were associated with experience in community pharmacy-led deprescribing.

In a conversation with David Blair, CEO of LucyRx, he discussed his company’s unique business model and how it is giving back to patients, providers, and plan sponsors alike.

Researchers conducted a study to understand how community pharmacist referrals translated to the acceptance and completion of annual wellness visits.

A majority of donors said that environmental concerns were an extremely important reason to practice safe medication disposal.

In this episode of the podcast, Shawn and Jesse outline 3 key principles about teamwork that can drive success in the pharmacy.

Antonio Ciaccia, President of 3 Axis Advisors, led a discussion on pharmacy benefit manager reform and how the inability to pass legislation has led to increased financial hardships in community pharmacy.

Lucas Berenbrok, PharmD, MS, discussed pharmacy deserts and how closures around the US have the potential to impact public health.

A conversation with Rob Frankil, RPh, executive director of the Philadelphia Association of Retail Druggists.

Chichi Ilonzo Momah, PharmD, discussed what pharmacists can be doing to address vaccine hesitancy and the barriers impeding under-resourced communities.

Cencora representatives with expertise into pharmacy desert insights joined Drug Topics to discuss issues in pharmacy access and what is being done to address them.

Don Roosan, PharmD, PhD, joined Drug Topics to explore the future of ChatGPT in pharmacy practice and how AI is being used to manage patients’ medication regimens.

In an Axios analysis of US Senate lobbying disclosures from the past year, researchers explored the ongoing trends of how certain industries distribute influence among legislators.

Jennifer Zilka and Kyle Pudenz, DBA, from Cencora joined Drug Topics to discuss the role of independent pharmacies in addressing pharmacy deserts across the US.

The top reported barriers to providing buprenorphine included regulatory and administrative, operational and attitudinal, and patient-related challenges.

Using a novel pharmacy vulnerability index, researchers identified US regions at the most risk of becoming pharmacy deserts.

A new report from the American Economic Liberties Project presents the continued challenges pharmacies face since Congress’ failure to pass PBM reform at the end of 2024.

US Senators on both sides of the aisle came together to announce the Protecting Pharmacies in Medicaid Act.

Representatives from Cencora’s Good Neighbor Pharmacy Network discussed legislation created to improve declining pharmacy rates and who is accountable for addressing pharmacy deserts.